City

Houston (1)

Seattle (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

University of Washington (1)

Collaborator

AbbVie (1)

Intervention

venetoclax (2)

cladribine (1)

cytarabine (1)

mitoxantrone (1)

omacetaxine mepesuccinate (1)

recombinant granulocyte colony-stimulating factor (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (2)

Study Type

Interventional (2)

refractory acute biphenotypic leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Recruiting

Hematopoietic and Lymphoid Cell Neoplasm
+6 more

Omacetaxine Mepesuccinate
Venetoclax

Houston, Texas

M D Anderson Cancer Center

Dec 31, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting

Acute Biphenotypic Leukemia
+11 more

Cladribine
+4 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Oct 18, 2022